Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-09-12 4:21 pm Purchase | 13G | Aligos Therapeutics Inc. ALGS | ICS OPPORTUNITIES II LLC | 125,451 4.1% | 125,451 (New Position) | View |
| 2024-02-14 5:07 pm Purchase | 13G | Aligos Therapeutics Inc. ALGS | EcoR1 Capital LLC | 7,264,147 9.99% | 3,315,787 (+83.98%) | View |
| 2024-02-14 4:37 pm Purchase | 13G | Aligos Therapeutics Inc. ALGS | HHLR ADVISORS LTD. | 5,971,426 8.2% | 3,661,662 (+158.53%) | View |
| 2024-02-14 4:21 pm Purchase | 13G | Aligos Therapeutics Inc. ALGS | BAKER BROS. ADVISORS LP | 3,664,013 4.99% | 1,587,613 (+76.46%) | View |
| 2024-02-14 4:00 pm Sale | 13G | Aligos Therapeutics Inc. ALGS | TANG CAPITAL PARTNERS LP | 2,189,847 3% | -626,544 (-22.25%) | View |
| 2024-02-14 3:23 pm Purchase | 13G | Aligos Therapeutics Inc. ALGS | ARMISTICE CAPITAL LLC | 7,214,823 9.99% | 7,214,823 (New Position) | View |
| 2024-02-14 1:53 pm Purchase | 13G | Aligos Therapeutics Inc. ALGS | Alyeska Investment Group L.P. | 7,176,767 9.99% | 7,176,767 (New Position) | View |
| 2024-02-08 5:44 pm Unchanged | 13D | Aligos Therapeutics Inc. ALGS | Versant Venture Capital VI L.P. | 1,457,937 1.9% | 0 (Unchanged) | View |
| 2023-11-07 5:16 pm Purchase | 13G | Aligos Therapeutics Inc. ALGS | ROCHE FINANCE LTD | 11,025,941 15.35% | 7,933,601 (+256.56%) | View |
| 2023-11-06 4:05 pm Purchase | 13D | Aligos Therapeutics Inc. ALGS | BLATT LAWRENCE | 3,888,253 5.3% | 1,210,283 (+45.19%) | View |
| 2023-11-02 4:08 pm Purchase | 13G | Aligos Therapeutics Inc. ALGS | Deep Track Capital LP | 7,295,967 9.99% | 7,295,967 (New Position) | View |
| 2023-02-14 4:10 pm Sale | 13G | Aligos Therapeutics Inc. ALGS | HHLR ADVISORS LTD. | 2,309,764 5.8% | -55,300 (-2.34%) | View |
| 2023-02-14 4:00 pm Purchase | 13G | Aligos Therapeutics Inc. ALGS | TANG CAPITAL PARTNERS LP | 2,816,391 7.1% | 457,491 (+19.39%) | View |
| 2023-02-13 08:25 am Purchase | 13G | Aligos Therapeutics Inc. ALGS | EcoR1 Capital LLC | 3,948,360 9.9% | 735,060 (+22.88%) | View |
| 2023-02-09 10:34 am Sale | 13G | Aligos Therapeutics Inc. ALGS | JANUS HENDERSON GROUP PLC JHG | 0 0% | -2,419,613 (Position Closed) | View |
| 2023-02-08 4:58 pm Purchase | 13G | Aligos Therapeutics Inc. ALGS | BLATT LAWRENCE | 2,677,970 6.5% | 168,593 (+6.72%) | View |
| 2022-12-27 5:06 pm Purchase | 13G | Aligos Therapeutics Inc. ALGS | TANG CAPITAL PARTNERS LP | 2,358,900 5.9% | 2,358,900 (New Position) | View |
| 2022-02-14 4:55 pm Purchase | 13G | Aligos Therapeutics Inc. ALGS | EcoR1 Capital LLC | 3,213,300 7.5% | 3,213,300 (New Position) | View |
| 2022-02-14 4:32 pm Sale | 13G | Aligos Therapeutics Inc. ALGS | Logos Global Management LP | 0 0% | -2,872,785 (Position Closed) | View |
| 2022-02-14 4:13 pm Purchase | 13G | Aligos Therapeutics Inc. ALGS | BAKER BROS. ADVISORS LP | 2,076,400 5.3% | 2,076,400 (New Position) | View |